A topical vitiligo treatment, artificial-intelligence-powered radiology and next-gen vaccine manufacturing are just some of the leading biopharma products that have been placed on Clarivate’s Top 100 New Brands report.
This annual report for the consultancy’s leading 100 brands of 2022, which aren’t ranked, come from Clarivate’s assessment of new brands with trademark protections filed predominantly in 2021-22.
This year 12 of those 100 brands are made up of drugs, digital products and medical technologies coming from across the life sciences industry.
These include two from Germany’s BioNTech, the biotech company that partnered with Pfizer to develop the world’s first mRNA vaccine for COVID, which is on the list for itself as a company, and also for its “BioNTainer” project, a vaccine manufacturing container solution that can be used around the globe.
Also on the list is Incyte, with its topical vitiligo JAK inhibitor drug Opzelura as one of two brands from the U.S. biopharma.
With a very different product is Germany’s Bayer, which was named for its Calantic Digital Solutions, the new cloud-based platform that aims to help automate various routine tasks across the radiologist’s workflow.
As part of that project, Bayer is also using digital and AI-powered apps for medical imaging, creating a virtual marketplace that will house vendor-neutral programs for speeding up patient reviews, automatically triaging serious cases and flagging scans of suspicious lesions.
Overall, however, biopharma had a poorer showing in 2022 than it did the year before: Those 12 products are nearly half of the 21 we saw in the Top 100 new Brands List from Clarivate last year.
That may be because the last report was focused on the COVID pandemic, a period where the global spotlight shone the most brightly on biopharma and was likely a major factor in highlighting the industry and its brands. Indeed, several COVID vaccines from Pfizer/BioNTech and Novavax made last year’s list.
As with biopharma’s reputation and reach, which has also slowly declined since 2021, it appears as if the same slide is happening with the view of its brand innovation.
Other leading brands in the top 100 come from across a wide spectrum and include products such as the Apple Watch Ultra, BOSS Camel from Hugo Boss and Dolce Gusto Neo from Nescafe.